Free Amended Complaint - District Court of California - California


File Size: 33.8 kB
Pages: 11
Date: December 31, 1969
File Format: PDF
State: California
Category: District Court of California
Author: unknown
Word Count: 3,323 Words, 21,189 Characters
Page Size: 611.99 x 791.99 pts (let
URL

https://www.findforms.com/pdf_files/cand/196051/10-1.pdf

Download Amended Complaint - District Court of California ( 33.8 kB)


Preview Amended Complaint - District Court of California
Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 1 of 11

1 2 3 4 5 6 7 8

MICHAEL A. JACOBS (CA SBN 111664) [email protected] GRANT L. KIM (CA SBN 114989) [email protected] RICHARD S.J. HUNG (CA SBN 197425) [email protected] MORRISON & FOERSTER LLP 425 Market Street San Francisco, CA 94105 Telephone: (415) 268-7000 Facsimile: (415) 268-7522 Attorneys for Plaintiff KYPHON INC. UNITED STATES DISTRICT COURT

9 NORTHERN DISTRICT OF CALIFORNIA 10 11 KYPHON INC., 12 Plaintiff, 13 v. 14 15 16 Defendant(s). 17 18 19 20 PARTIES 21 22 23 24 25 26 27 28
FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

Case No.

07-3403 JF

COZMED, LLC, a limited liability corporation, and PETER K. PARK, an individual,

FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT, TRADE SECRET MISAPPROPRIATION, TORTIOUS INTERFERENCE WITH CONTRACTUAL RELATIONS, AND CONVERSION DEMAND FOR JURY TRIAL

Plaintiff Kyphon Inc., for its First Amended Complaint, alleges as follows:

1.

Plaintiff Kyphon is a corporation incorporated under the laws of the State of

Delaware with its principal place of business at 1221 Crossman Avenue, Sunnyvale, California 94089. 2. Kyphon is a pioneer in the field of kyphoplasty, a minimally invasive surgical

procedure for repairing spinal fractures. Such fractures may result from osteoporosis, cancer, or medical treatments such as chemotherapy. Balloon kyphoplasty involves the surgical insertion of a specially-designed balloon into the fractured bones of the spine to raise them and restore them 1

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 2 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

to their correct position. As a result, kyphoplasty can help relieve the significant back pain and stooped posture that many spinal fracture sufferers experience. 3. Defendant Cozmed, LLC, sometimes referred to as "Cozumed," is a California

limited liability corporation with its principal place of business at 41909 Albrae Street, Fremont, California, 94538. 4. Defendant Peter K. Park is the President and Operating Manager for Cozmed. JURISDICTION AND VENUE 5. This is an action for patent infringement arising under the patent laws of the

United States, Title 35 of the United States Code and for trade secret misappropriation, tortious interference with contractual relations, and conversion. This Court has subject matter jurisdiction under 28 U.S.C. § 1331 (federal question) and § 1338(a) (patents). This Court has subject matter jurisdiction over the trade secret misappropriation, tortious interference, and conversion claims under 28 U.S.C. § 1367(a) (supplemental jurisdiction). 6. Cozmed is subject to personal jurisdiction in this District because its principal

place of business is in this District and Cozmed has committed acts of patent infringement, trade secret misappropriation, and conversion in this District. 7. Mr. Park is subject to personal jurisdiction in this District because he works and

lives in this District and has committed acts of patent infringement, trade secret misappropriation, tortious interference, and conversion in this District. 8. Venue is proper under 28 U.S.C. §§ 1391, 1400(b). INTRADISTRICT ASSIGNMENT 9. Pursuant to Civil L.R. 3-2(c), the Intradistrict Assignment rules do not apply to

this Complaint. FIRST CAUSE OF ACTION (Infringement of U.S. Patent No. 6,607,544 by Cozmed and Mr. Park) 10. above. Kyphon incorporates by reference the allegations contained in paragraphs 1-9

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

2

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 3 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 above.

11.

Kyphon is the owner by assignment of all rights, title, and interest in and to United

States Patent No. 6,607,544 ("the '544 patent"), issued on August 19, 2003 and entitled "Expandable Preformed Structures for Deployment in Interior Body Regions." The '544 patent is attached as Exhibit A. 12. Cozmed and Mr. Park are infringing or have infringed the '544 patent directly or

indirectly under 35 U.S.C. § 271 by making, using, offering for sale, or selling products for use in performing kyphoplasty. Defendants' products encompass an invention claimed by the '544 patent or are a substantial part of such an invention. Defendants' products are specially made or adapted for use in an invention claimed by the '544 patent and are not staple articles or commodities of commerce suitable for substantial non-infringing uses. Upon information and belief, Defendants knowingly and actively have instructed or continue to instruct purchasers in the use of their products in a manner that infringes or would infringe the '544 patent. 13. Defendants' infringement is without the consent or other authority of Kyphon.

Neither Cozmed nor Mr. Park is licensed under the '544 patent. 14. On information and belief, Defendants have infringed or are infringing the '544

patent despite their knowledge of the objectively high likelihood that their conduct constituted or constitutes infringement. As a result, Defendants' infringement of the '544 patent has been or continues to be willful. 15. Kyphon is entitled to damages for Defendants' infringement of the '544 patent and

trebled damages for Defendants' willful infringement of the '544 patent. 16. Kyphon has no adequate legal remedy. Unless enjoined by this Court,

Defendants' continued acts of infringement will cause Kyphon substantial and irreparable harm. Under 35 U.S.C. § 283, Kyphon is entitled to an injunction barring Defendants from further infringement of the '544 patent. SECOND CAUSE OF ACTION (Infringement of U.S. Patent No. 6,623,505 by Cozmed and Mr. Park) 17. Kyphon incorporates by reference the allegations contained in paragraphs 1-16

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

3

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 4 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 above.

18.

Kyphon is the owner by assignment of all rights, title, and interest in and to United

States Patent No. 6,623,505 ("the '505 patent"), issued on September 23, 2003 and entitled "Expandable Structures for Deployment in Interior Body Regions." The '505 patent is attached as Exhibit B. 19. Cozmed and Mr. Park are infringing or have infringed the '505 patent directly or

indirectly under 35 U.S.C. § 271 by making, using, offering for sale, or selling products for use in performing kyphoplasty. Defendants' products encompass an invention claimed by the '505 patent or are a substantial part of such an invention. Defendants' products are specially made or adapted for use in an invention claimed by the '505 patent and are not staple articles or commodities of commerce suitable for substantial non-infringing uses. Upon information and belief, Defendants knowingly and actively have instructed or continue to instruct purchasers in the use of their products in a manner that infringes or would infringe the '505 patent. 20. Defendants' infringement is without the consent or other authority of Kyphon.

Neither Cozmed nor Mr. Park is licensed under the '505 patent. 21. On information and belief, Defendants have infringed or are infringing the '505

patent despite their knowledge of the objectively high likelihood that their conduct constituted or constitutes infringement. As a result, Defendants' infringement of the '505 patent has been or continues to be willful. 22. Kyphon is entitled to damages for Defendants' infringement of the '505 patent

and trebled damages for Defendants' willful infringement of the '505 patent. 23. Kyphon has no adequate legal remedy. Unless enjoined by this Court,

Defendants' continued acts of infringement will cause Kyphon substantial and irreparable harm. Under 35 U.S.C. § 283, Kyphon is entitled to an injunction barring Defendants from further infringement of the '505 patent. THIRD CAUSE OF ACTION (Infringement of U.S. Patent No. 6,979,341 by Cozmed and Mr. Park) 24. Kyphon incorporates by reference the allegations contained in paragraphs 1-23

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

4

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 5 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 above.

25.

Kyphon is the owner by assignment of all rights, title, and interest in and to United

States Patent No. 6,979,341 ("the '341 patent"), issued on December 27, 2005 and entitled "Expandable Preformed Structures for Deployment in Interior Body Regions." The '341 patent is attached as Exhibit C. 26. Cozmed and Mr. Park are infringing or have infringed the '341 patent directly or

indirectly under 35 U.S.C. § 271 by making, using, offering for sale, or selling products for use in performing kyphoplasty. Defendants' products encompass an invention claimed by the '341 patent or are a substantial part of such an invention. Defendants' products are specially made or adapted for use in an invention claimed by the '341 patent and are not staple articles or commodities of commerce suitable for substantial non-infringing uses. Upon information and belief, Defendants knowingly and actively have instructed or continue to instruct purchasers in the use of their products in a manner that infringes or would infringe the '341 patent. 27. Defendants' infringement is without the consent or other authority of Kyphon.

Neither Cozmed nor Mr. Park is licensed under the '341 patent. 28. On information and belief, Defendants have infringed or are infringing the '341

patent despite their knowledge of the objectively high likelihood that their conduct constituted or constitutes infringement. As a result, Defendants' infringement of the '341 patent has been or continues to be willful. 29. Kyphon is entitled to damages for Defendants' infringement of the '341 patent

and trebled damages for Defendants' willful infringement of the '341 patent. 30. Kyphon has no adequate legal remedy. Unless enjoined by this Court,

Defendants' continued acts of infringement will cause Kyphon substantial and irreparable harm. Under 35 U.S.C. § 283, Kyphon is entitled to an injunction barring Defendants from further infringement of the '341 patent. FOURTH CAUSE OF ACTION (Trade Secret Misappropriation by Cozmed and Mr. Park) 31. Kyphon incorporates by reference the allegations contained in paragraphs 1-30

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

5

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 6 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

32.

Through substantial investments of time, labor, and capital, Kyphon has developed

information constituting trade secrets under the Uniform Trade Secrets Act, as codified at California Civil Code sections 3426 et seq. Kyphon's trade secrets derive independent economic value from not being generally known to the public or to persons who can obtain economic value from their disclosure or use. Kyphon has consistently and diligently undertaken reasonable steps to maintain the secrecy of its trade secrets. 33. Lenny Chi Phan previously was an employee with Kyphon between April 2000

and March 2005. During and as a result of his employment with Kyphon, Mr. Phan learned of Kyphon's trade secrets relating to its business and its kyphoplasty products. 34. Mr. Phan was and continues to be under a duty to maintain the secrecy of

Kyphon's trade secrets. On April 5, 2000, Mr. Phan executed a Proprietary Information Agreement. Under paragraph 2(a) of the Proprietary Information Agreement, Mr. Phan agreed that, "at all times during the term of [his] employment and thereafter, [he would] hold in strictest confidence, and not . . . use, except for the benefit of the Company, or . . . disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Confidential Information of the Company." On February 28, 2005, Mr. Phan signed a Termination Certification, in which he agreed that he would "preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees." 35. Cozmed and Mr. Park acquired Kyphon's trade secrets using improper means,

including inducing Mr. Phan to breach his duty to maintain the secrecy of Kyphon's trade secrets. Alternatively, Cozmed and Mr. Park knew or had reason to know that their knowledge of Kyphon's trade secrets was derived from or through a person who had utilized improper means to acquire it, was acquired under circumstances giving rise to a duty to maintain the secrecy or limit

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

6

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 7 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

the use of Kyphon's trade secrets, or was derived from or through Mr. Phan or another person who owed a duty to Kyphon to maintain the secrecy or limit the use of Kyphon's trade secrets. 36. Defendants have acquired, disclosed, or used or continue to disclose or use

Kyphon's trade secrets, despite knowing or having reason to know that Kyphon's trade secrets were acquired through improper means and that their acquisition, disclosure, or use is without Kyphon's express or implied consent. 37. As a result of Defendants' misappropriation of Kyphon's trade secrets, Kyphon

has suffered and will continue to suffer damages. 38. Kyphon has no adequate legal remedy. Unless enjoined by this Court,

Defendants' continued disclosure or use of Kyphon's trade secrets will cause Kyphon substantial and irreparable harm. Under California Civil Code section 3426.2, Kyphon is entitled to an injunction barring Defendants from further misappropriation of Kyphon's trade secrets. 39. On information and belief, Defendants' misappropriation of Kyphon's trade

secrets was and is willful and malicious, entitling Kyphon to an award of exemplary damages and to its reasonable attorneys' fees and costs in this matter. FIFTH CAUSE OF ACTION (Tortious Interference with Contractual Relations by Mr. Park) 40. above. 41. Mr. Phan previously was an employee with Kyphon between April 2000 and Kyphon incorporates by reference the allegations contained in paragraphs 1-39

March 2005. On April 5, 2000, Mr. Phan executed a Proprietary Information Agreement. Under paragraph 2(a) of the Proprietary Information Agreement, Mr. Phan agreed that, "at all times during the term of [his] employment and thereafter, [he would] hold in strictest confidence, and not . . . use, except for the benefit of the Company, or . . . disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Confidential Information of the Company." On February 28, 2005, Mr. Phan signed a Termination Certification, in which he agreed that he would "preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products,
FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

7

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 8 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

processes, know-how, designs, formulas, developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees, clients, consultants or licensees." 42. Mr. Park knew or should have known of Mr. Phan's contractual relations with

Kyphon, but intentionally acted to disrupt these relations. Before or after Mr. Phan's March 1, 2005 resignation from Kyphon, Mr. Park intended to encourage and did encourage Mr. Phan to breach the terms of the Proprietary Information Agreement and Termination Certification by disclosing confidential information and materials concerning Kyphon and its kyphoplasty products to Mr. Park or to other individuals, such as individuals in the Republic of Korea. 43. As a result of Mr. Park's tortious interference with Kyphon's contractual relations

with Mr. Phan, Kyphon has suffered and will continue to suffer damages. SIXTH CAUSE OF ACTION (Conversion by Cozmed and Mr. Park) 44. above. 45. During his employment with Kyphon, Mr. Phan removed all or parts of Kyphon's Kyphon incorporates by reference the allegations contained in paragraphs 1-43

bonding and balloon machines and other components used to manufacture Kyphon's kyphoplasty products or relating to kyphoplasty from Kyphon's premises at Mr. Park's request. Cozmed and Mr. Park have assumed control or ownership over these materials and used them to manufacture kyphoplasty machines, devices, or components for persons or companies other than Kyphon. 46. Cozmed and Mr. Park's conversion of Kyphon's property has interfered with

Kyphon's ownership rights in this property. Defendants' conversion was performed without Kyphon's express or implied authorization. 47. As a result of Cozmed and Mr. Park's conversion of Kyphon's property, Kyphon

has suffered and will continue to suffer damages. WHEREFORE, Kyphon requests judgment:

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

8

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 9 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

A.

Declaring that Cozmed and Mr. Park have infringed the '544, '505, and '341 patents;

B.

Declaring that Cozmed and Mr. Park have misappropriated Kyphon's trade secrets;

C.

Declaring that Mr. Park has tortiously interfered with Kyphon's contractual relations with Mr. Phan;

D. E.

Declaring that Cozmed and Mr. Park have converted Kyphon's property; Preliminarily and permanently enjoining Cozmed and Mr. Park and their employees, agents, servants, or any other person or entity acting in privity or in concert with them from further infringement of the '544, '505, and '341 patents;

F.

Preliminarily and permanently enjoining Cozmed and Mr. Park and their employees, agents, servants, or any other person or entity acting in privity or in concert with them from further misappropriation of Kyphon's trade secrets;

G.

Preliminarily and permanently enjoining Mr. Park and his employees, agents, servants, or any other person or entity acting in privity or in concert with him from continuing to interfere with Kyphon's contractual relations with Mr. Phan;

H.

Ordering Cozmed and Mr. Park to return the property that was removed from Kyphon's premises without authorization;

I.

Awarding Kyphon its damages, together with pre-judgment interest and costs, for Cozmed and Mr. Park's infringement of the '544, '505, and '341 patents, and increasing said damages by up to three times under 35 U.S.C. § 284;

J.

Awarding Kyphon its damages, together with pre-judgment interest and costs, for Cozmed and Mr. Park's misappropriation of Kyphon's trade secrets;

K.

Awarding Kyphon its damages, together with pre-judgment interest and costs, for Mr. Park's tortious interference with Kyphon's contractual relations with Mr. Phan;

L.

Awarding Kyphon its damages, together with pre-judgment interest and costs, for Cozmed and Mr. Park's conversion of Kyphon's property;

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

9

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 10 of 11

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

M.

Declaring Cozmed and Mr. Park's infringement of the '544, '505, and '341 patents to be willful;

N. O.

Declaring this to be an exceptional case under 35 U.S.C. § 285; Declaring Cozmed and Mr. Park's misappropriation of Kyphon's trade secrets to be willful and malicious;

P.

Awarding Kyphon exemplary damages for Cozmed and Mr. Park's trade secret misappropriation;

Q.

Awarding Kyphon its reasonable attorneys' fees, costs, and disbursements in this action, with interest; and

R.

Awarding Kyphon such other and further relief as this Court may deem just and proper.

Dated: October 22, 2007

MICHAEL A. JACOBS GRANT L. KIM RICHARD S.J. HUNG MORRISON & FOERSTER LLP

By:

/s/ Richard S.J. Hung Attorneys for Plaintiff

FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

10

Case 5:07-cv-03403-JF

Document 10

Filed 10/22/2007

Page 11 of 11

1 2 3 4 5 6 7 8 Dated: October 22, 2007

DEMAND FOR JURY TRIAL Kyphon Inc. demands a trial by jury of any and all issues triable of right by a jury in the above-captioned action.

MICHAEL A. JACOBS GRANT L. KIM RICHARD S.J. HUNG MORRISON & FOERSTER LLP

By: 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
FIRST AMENDED COMPLAINT CASE NO. 07-3403-JF sf-2336243

/s/ Richard S.J. Hung Attorneys for Plaintiff

11